Brief: Kiniksa Outlines Next Steps For The Development Of Mavrilimumab

Kiniksa Pharmaceuticals International

08/06/2021 12:36

June 8 (Reuters) - Kiniksa Pharmaceuticals Ltd  KNSA.O :
    * KINIKSA OUTLINES NEXT STEPS FOR THE DEVELOPMENT OF
MAVRILIMUMAB
    * KINIKSA PHARMACEUTICALS LTD - DEFINED REGULATORY PATHWAY
FOR
PHASE 3 CLINICAL DEVELOPMENT OF MAVRILIMUMAB IN MULTIPLE
INDICATIONS
    * KINIKSA PHARMACEUTICALS LTD - CONTINUED DEVELOPMENT IN
COVID-19-RELATED ARDS REPRESENTS FASTEST PATH TO POTENTIAL
REGISTRATION FOR MAVRILIMUMAB

Source text for Eikon:  ID:nGNXbMGD4S 
Further company coverage:  KNSA.O 

 ((Reuters.Briefs@thomsonreuters.com;))